Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient.Amniotic's platform enables the extraction of Mesenchymal Stem Cells (MSC) from amniotic fluid, which is recovered from healthy voluntary donors in connection with planned caesarean sections.Amniotics has a project portfolio where the same technology and methodology can be...
We are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient.Amniotic's platform enables the extraction of Mesenchymal Stem Cells (MSC) from amniotic fluid, which is recovered from healthy voluntary donors in connection with planned caesarean sections.Amniotics has a project portfolio where the same technology and methodology can be applied for various indications.Our procedure for collecting term amniotic fluid from voluntary healthy donors is performed at full-term planned caesarean deliveries.

List your booth number for exhibitions, ask us